Diffuse large B-cell lymphoma trials in Austria
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
- Where
- Graz, Leoben, Linz, Vienna, Wels
- Age
- 18 years and over
- People
- 904 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091865 · EU 2022-502785-25-00 - Phase 3Taking peopleAge-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – a randomized phase III trial - PRIMA-CNS
- Where
- Graz, Innsbruck, Linz
- Age
- 65 years and over
- People
- 260 worldwide
- Run by
- Medical Center - University Of Freiburg
See details and how to join2024-512320-11-00 · EU 2024-512320-11-00 - Phase 2Taking peopleEfficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
- Where
- Graz, Innsbruck, Linz, Vienna
- Age
- 18 years to 70 years
- People
- 213 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT04844866 · EU 2023-506270-13-00 - No phaseTaking peopleReal-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
- Where
- Graz, Leoben
- Age
- 18 years and over
- People
- 700 worldwide
- Run by
- AbbVie
See details and how to joinNCT06830759 - Early phase 1Not yet taking people in AustriaImmunoMRI for Assessment of Tumor-associated Macrophages
- Where
- Vienna
- Age
- 18 years and over
- People
- 60
- Run by
- Medical University of Vienna
See details and how to joinNCT07066436